Quick Answer
Pharmagreen Biotech Inc. reported Operating Income of -$1.10 million for fiscal year 2022.
Pharmagreen Biotech Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2022 | -$1.10M | -48.0% |
| 2021 | -$744.1K | -53.2% |
| 2020 | -$485.8K | +24.4% |
| 2019 | -$642.2K | +14.2% |
| 2018 | -$748.7K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | -$188.0K | +81.9% | -3.8% |
| December 31, 2022 | -$181.1K | +11.1% | +24.9% |
| June 30, 2022 | -$241.2K | -3.8% | +76.7% |
| March 31, 2022 | -$1.04M | -656.3% | -408.6% |
| December 31, 2021 | -$203.7K | — | +12.4% |
| June 30, 2021 | -$232.4K | -167.4% | -69.7% |
| March 31, 2021 | -$136.9K | +9.1% | -57.6% |
| June 30, 2020 | -$86.9K | -49.0% | +42.3% |
- Pharmagreen Biotech Inc. showed a decrease of -48.0% in Operating Income compared to the prior fiscal year.
- Over the 2018–2022 period, Pharmagreen Biotech Inc.’s operating income has declined by 47.1% (from -$748.7 thousand to -$1.10 million).
- The most recent figure is from Pharmagreen Biotech Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on January 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: